NasdaqGS - Nasdaq Real Time Price USD

GoodRx Holdings, Inc. (GDRX)

7.19

+0.11

(+1.55%)

At close: April 26 at 4:00 PM EDT

7.03

-0.16

(-2.23%)

After hours: April 26 at 7:24 PM EDT

GoodRx Announces Date for 2024 Investor Day

SANTA MONICA, Calif., April 24, 2024--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., today announced it will hold its first Investor Day on May 15, 2024, in New York City. The event will begin at 9:00 a.m. Eastern Time (6:00 a.m. Pacific Time).

Business Wire 4 days ago
GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call

SANTA MONICA, Calif., April 11, 2024--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., today announced it will release its first quarter 2024 financial results before U.S. markets open on Thursday, May 9, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook.

Business Wire 17 days ago
GoodRx Interim CEO Extends Commitment to Company

SANTA MONICA, Calif., March 14, 2024--GoodRx Holdings, Inc. (Nasdaq: GDRX), the leading destination for prescription savings in the U.S., today announced Interim CEO Scott Wagner has extended his commitment to the Company. In addition, Stephen LeSieur and Adam Karol have notified GoodRx of their decision to resign from the Company’s Board of Directors, effective March 14, 2024 and March 22, 2024, respectively.

Business Wire last month
GoodRx Reports Fourth Quarter and Full Year 2023 Results

SANTA MONICA, Calif., February 29, 2024--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial results for the fourth quarter and full year 2023, which are consistent with its preliminary results announced on January 10, 2024.

Business Wire last month
GoodRx to Participate in Upcoming Investor Conferences

SANTA MONICA, Calif., February 20, 2024--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., today announced that executives from the Company will participate in a fireside chat at each of the following investor conferences:

Business Wire 2 months ago
GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

SANTA MONICA, Calif., February 01, 2024--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S, today announced it will release its fourth quarter and full year 2023 financial results before U.S. markets open on Thursday, February 29, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook.

Business Wire 2 months ago
GoodRx Announces Proposed Refinancing of First Lien Credit Facilities

SANTA MONICA, Calif., January 22, 2024--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings, today announced its intention to refinance its first lien credit facilities.

Business Wire 3 months ago
The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings

SANTA MONICA, Calif., January 11, 2024--GoodRx (NASDAQ: GDRX), the leading destination for prescription savings, today shared a report looking at the company’s impact on social welfare as a result of helping millions of people access affordable medications. "The GoodRx Effect: How GoodRx is Changing the Economics of Healthcare" shows that by saving people money and improving medication adherence, GoodRx positively impacts health outcomes and significantly reduces costs within the healthcare syst

Business Wire 3 months ago
GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024

SANTA MONICA, Calif., January 10, 2024--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings, today provided preliminary unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023.

Business Wire 3 months ago
GoodRx Appoints Kelly J. Kennedy to Board of Directors

SANTA MONICA, Calif., December 22, 2023--GoodRx (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced the election of Kelly J. Kennedy to its Board of Directors. Kennedy will serve as a member of the Board’s audit committee and fill the seat left vacant by Jacqueline Kosecoff earlier this year.

Business Wire 4 months ago
GoodRx to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

SANTA MONICA, Calif., December 13, 2023--GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced that executives from the Company will participate in a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 10, 2024 at 8:15 a.m. Pacific Time (11:15 a.m. Eastern Time).

Business Wire 4 months ago
GoodRx to Participate in the Evercore ISI HealthCONx Conference

SANTA MONICA, Calif., November 16, 2023--GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced that executives from the Company will participate in a fireside chat at the Evercore ISI HealthCONx Conference in Miami, FL on Thursday, November 30, 2023 at 9:30 a.m. Pacific Time (12:30 p.m. Eastern Time).

Business Wire 5 months ago
GoodRx Reports Third Quarter 2023 Results

SANTA MONICA, Calif., November 09, 2023--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), a leading resource for healthcare savings and information, has released its financial results for the third quarter 2023.

Business Wire 5 months ago
GoodRx Announces New Way for Consumers to Access Sanofi’s Lantus for $35 at Over 70,000 Pharmacies Nationwide

SANTA MONICA, Calif., October 19, 2023--GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, today announced it is working with Sanofi (NASDAQ: SNY), a global leader in diabetes care, to offer a new way for people living with diabetes to access Lantus® (insulin glargine injection) 100 Units/mL in the U.S. for only $35.

Business Wire 6 months ago
GoodRx Announces Date for Third Quarter 2023 Earnings Release and Conference Call

SANTA MONICA, Calif., October 12, 2023--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), a leading resource for healthcare savings and information, today announced it will release its third quarter 2023 financial results before U.S. markets open on Thursday, November 9, 2023. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook.

Business Wire 6 months ago
GoodRx and Navitus Health Solutions Announce Savings Connect Program to Deliver Lower Prescription Prices for Navitus Members

SANTA MONICA, Calif., October 12, 2023--GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, and Navitus Health Solutions, LLC, a pass-through pharmacy benefit manager (PBM) committed to removing cost from the drug supply chain, today announced the launch of Savings Connect. This program, when elected by clients, provides members with automatic access to GoodRx prices on generic drugs in a seamless experience at the pharmacy counter. Consumers no longer have to proac

Business Wire 6 months ago
GoodRx Announces Significant Savings on Antivirals, Medications and Vaccines for Cold & Flu Season

SANTA MONICA, Calif., September 21, 2023--GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, today announced it is offering new savings on antivirals, medications and vaccines for the upcoming cold and flu season. Last flu season (October 1, 2022 through April 30, 2023), the CDC estimates that influenza was associated with more than 27 million illnesses, 300,000 hospitalizations, and 19,000 deaths, showing the importance of Americans taking preventative measures to

Business Wire 7 months ago
GoodRx and MedImpact Announce Program to Ensure Seamless Access to Affordable Prescriptions

SANTA MONICA, Calif. & SAN DIEGO, September 13, 2023--GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, and MedImpact, the independent pharmacy benefit manager (PBM) and health solutions company, today announced a new savings solution designed to integrate GoodRx’s prescription pricing in a seamless experience at the pharmacy counter. Now, when an eligible MedImpact member fills a prescription for a generic medication, it will automatically compare their benefit a

Business Wire 7 months ago
GoodRx Now Offers 40% More Savings on Nearly 200 Medications at Walgreens

SANTA MONICA, Calif., September 11, 2023--GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, today announced a new initiative at Walgreens to reduce prices on nearly 200 prescription medications by an average of 40%, with even greater savings available for select medications. Consumers can now purchase many popular prescriptions at Walgreens for less than $15 for a 30-day fill, without any deductibles, restrictions, paperwork, approvals or quantity limitations.

Business Wire 7 months ago
GoodRx to Present at the Morgan Stanley Global Healthcare Conference

SANTA MONICA, Calif., August 30, 2023--GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced that executives from the Company will be presenting at the Morgan Stanley Global Healthcare Conference in New York, NY on Wednesday, September 13, 2023 at 6:30 a.m. Pacific Time (9:30 a.m. Eastern Time).

Business Wire 7 months ago

Performance Overview

Return	GDRX	S&P 500
YTD	+7.31%	+6.92%
1-Year	+30.97%	+25.26%
3-Year	-81.83%	+22.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

GoodRx Holdings, Inc. (GDRX)

GoodRx Announces Date for 2024 Investor Day

GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call

GoodRx Interim CEO Extends Commitment to Company

GoodRx Reports Fourth Quarter and Full Year 2023 Results

GoodRx to Participate in Upcoming Investor Conferences

GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

GoodRx Announces Proposed Refinancing of First Lien Credit Facilities

The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings

GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024

GoodRx Appoints Kelly J. Kennedy to Board of Directors

GoodRx to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

GoodRx to Participate in the Evercore ISI HealthCONx Conference

GoodRx Reports Third Quarter 2023 Results

GoodRx Announces New Way for Consumers to Access Sanofi’s Lantus for $35 at Over 70,000 Pharmacies Nationwide

GoodRx Announces Date for Third Quarter 2023 Earnings Release and Conference Call

GoodRx and Navitus Health Solutions Announce Savings Connect Program to Deliver Lower Prescription Prices for Navitus Members

GoodRx Announces Significant Savings on Antivirals, Medications and Vaccines for Cold & Flu Season

GoodRx and MedImpact Announce Program to Ensure Seamless Access to Affordable Prescriptions

GoodRx Now Offers 40% More Savings on Nearly 200 Medications at Walgreens

GoodRx to Present at the Morgan Stanley Global Healthcare Conference

Performance Overview